This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldfarb, R. H. Articles by Quigley, J. P. Search for Related Content PubMed PubMed Citation Articles by Goldfarb, R. H. Articles by Quigley, J. P.

Synergistic Effect of Tumor Virus Transformation and Tumor Promoter Treatment on the Production of Plasminogen Activator by Chick Embryo Fibroblasts¹

Department of Microbiology and Immunology, State University of New York, Downstate Medical Center, Brooklyn, New York 11203

Cultures of Rous sarcoma virus-transformed chick embryo fibroblasts (RSVCEF) produce 50-fold more of the protease plasminogen activator (PA), than do normal chick embryo fibroblasts. Treatment of RSVCEF cultures with the tumor promoter phorbol myristate acetate (PMA) further enhances (8- to 12-fold) the level of PA activity. Increased levels of PA activity in RSVCEF are observed as early as 1 to 2 hr after PMA treatment. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrates that the PA produced by PMA-treated cultures has a molecular weight identical to that of the PA produced by untreated cultures. PA induction by PMA cannot be accomplished in cell-free extracts, but requires protein synthesis in intact cells. Under serum-free conditions, PMA-treated RSVCEF secrete high levels of PA for 4 to 6 days and undergo pronounced morphological alterations. Modified culture conditions and the use of PMA to induce PA has allowed for the accumulation of large amounts of RSVCEF culture fluid and the subsequent purification of the enzyme. The sensitivity of transformed CEF to PMA and the generation of enhanced proteolytic activity in the cellular microenvironment may provide a model system to examine the role of both PA in malignant transformation and PMA in tumor promotion.

¹ Supported in part by Grant BC 163 from the American Cancer Society and NIH Grant CA 16740.

² To whom requests for reprints should be addressed.

Received 7/ 3/78. Accepted 9/19/78.

This article has been cited by other articles:

				H. Rubin Complementary approaches to understanding the role of proteases and their natural inhibitors in neoplastic development: retrospect and prospect Carcinogenesis, May 1, 2003; 24(5): 803 - 816. [Abstract] [Full Text] [PDF]

				R. P. Kitson, P. M. Appasamy, U. Nannmark, P. Albertsson, M. K. Gabauer, and R. H. Goldfarb Matrix Metalloproteinases Produced by Rat IL-2-Activated NK Cells J. Immunol., May 1, 1998; 160(9): 4248 - 4253. [Abstract] [Full Text] [PDF]

				A. Goldberg, K. Delclos, and P. Blumberg Phorbol ester action is independent of viral and cellular src kinase levels Science, April 11, 1980; 208(4440): 191 - 193. [Abstract] [PDF]